The missing link between high-density lipoprotein cholesterol and inflammatory response in cardiovascular disease
| Main Authors: | Ammirati, E., Scotti, I., Norata, Giuseppe |
|---|---|
| Format: | Journal Article |
| Published: |
2014
|
| Online Access: | http://hdl.handle.net/20.500.11937/55978 |
Similar Items
Does cigarette smoking exacerbate the effect of total cholesterol and high-density lipoprotein cholesterol on the risk of cardiovascular diseases?
by: Nakamura, K., et al.
Published: (2009)
by: Nakamura, K., et al.
Published: (2009)
Vascular inflammation and low-density lipoproteins: Is cholesterol the link? A lesson from the clinical trials
by: Catapano, A., et al.
Published: (2017)
by: Catapano, A., et al.
Published: (2017)
Treating high density lipoprotein cholesterol (HDL-C): Quantity versus quality
by: Pirillo, A., et al.
Published: (2013)
by: Pirillo, A., et al.
Published: (2013)
High density lipoprotein cholesterol levels are an independent predictor of the progression of chronic kidney disease
by: Baragetti, A., et al.
Published: (2013)
by: Baragetti, A., et al.
Published: (2013)
Emerging role of high density lipoproteins as a player in the immune system
by: Norata, Giuseppe, et al.
Published: (2012)
by: Norata, Giuseppe, et al.
Published: (2012)
High density lipoproteins and atherosclerosis: Emerging aspects
by: Sala, F., et al.
Published: (2012)
by: Sala, F., et al.
Published: (2012)
Biology of proprotein convertase subtilisin kexin 9: Beyond low-density lipoprotein cholesterol lowering
by: Norata, Giuseppe, et al.
Published: (2016)
by: Norata, Giuseppe, et al.
Published: (2016)
High-density lipoprotein subfractions - What the clinicians need to know
by: Pirillo, A., et al.
Published: (2013)
by: Pirillo, A., et al.
Published: (2013)
Low density lipoprotein cholesterol phenotypes and their association with risk factors of cardiovascular disease among subjects attending health screening at a public university in Malaysia
by: Mazalan, Norlianah
Published: (2019)
by: Mazalan, Norlianah
Published: (2019)
Heterozygous mthfr c677t polymorphism (rs1801133) is associated with higher total cholesterol/ high density lipoprotein cholesterol ratio in habitual coffee drinkers
by: Ong, Xuan
Published: (2023)
by: Ong, Xuan
Published: (2023)
Trained immunity and cardiovascular disease: Is it time for translation to humans?
by: Norata, Giuseppe
Published: (2018)
by: Norata, Giuseppe
Published: (2018)
Oxidizes Low Density Lipoprotein Cytoxicity and Vascular Diseases
by: Gieseg, Steven P., et al.
Published: (2009)
by: Gieseg, Steven P., et al.
Published: (2009)
Plasma triglyceride and high density lipoprotein cholesterol are poor surrogate markers of pro-atherogenic chylomicron remnant homeostasis in subjects with the metabolic syndrome
by: Irawati, D., et al.
Published: (2016)
by: Irawati, D., et al.
Published: (2016)
Efficacy of Ganoderma lucidum on plasma lipids and lipoproteins in rats fed with high cholesterol diet
by: Tong, Chow Chin, et al.
Published: (2008)
by: Tong, Chow Chin, et al.
Published: (2008)
Factors associated with nonachievement of low density
lipoprotein cholesterol target among patients with type 2 diabetes mellitus
by: Mat Yudin, Zainab
Published: (2015)
by: Mat Yudin, Zainab
Published: (2015)
Increased risk of cardiovascular disease in Type 1 diabetes: arterial exposure to remnant lipoproteins leads to enhanced deposition of cholesterol and binding to glycated extracellular matrix proteoglycans
by: Mangat, R., et al.
Published: (2011)
by: Mangat, R., et al.
Published: (2011)
Isolated low levels of high-density lipoprotein cholesterol are associated with an increased risk of coronary heart disease: An individual participant data meta-analysis of 23 studies in the asia-pacific region
by: Huxley, Rachel, et al.
Published: (2011)
by: Huxley, Rachel, et al.
Published: (2011)
Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease
by: Yusuf, S., et al.
Published: (2016)
by: Yusuf, S., et al.
Published: (2016)
Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease
by: Yusuf, S., et al.
Published: (2016)
by: Yusuf, S., et al.
Published: (2016)
The Interplay of Lipids, Lipoproteins, and Immunity in Atherosclerosis
by: Pirillo, A., et al.
Published: (2018)
by: Pirillo, A., et al.
Published: (2018)
Blood-pressure and cholesterol lowering in persons without cardiovascular disease
by: Yusuf, Salim, et al.
Published: (2016)
by: Yusuf, Salim, et al.
Published: (2016)
Cholesterol lowering in intermediate-risk persons without cardiovascular disease
by: Yusuf, Salim, et al.
Published: (2016)
by: Yusuf, Salim, et al.
Published: (2016)
Soluble inflammatory biomarkers and apolipoprotein A1 gene variants in low high density lipoprotein concentration / Nurul Atiqah Mohd Mokhsin
by: Mohd Mokhsin, Nurul Atiqah
Published: (2016)
by: Mohd Mokhsin, Nurul Atiqah
Published: (2016)
Is liquidity the missing link?
by: Limkriangkrai, M., et al.
Published: (2008)
by: Limkriangkrai, M., et al.
Published: (2008)
MicroRNAs and lipoproteins: A connection beyond atherosclerosis?
by: Norata, Giuseppe, et al.
Published: (2013)
by: Norata, Giuseppe, et al.
Published: (2013)
Inflammation Beats Cholesterol: A Comment on the Unequivocal Driver of Cardiovascular Disease Risk
by: Vaccarezza, Mauro, et al.
Published: (2023)
by: Vaccarezza, Mauro, et al.
Published: (2023)
Cholesterol metabolism and transport in the pathogenesis of Alzheimer's disease
by: Martins, I.j, et al.
Published: (2009)
by: Martins, I.j, et al.
Published: (2009)
Long pentraxin PTX3 as a prognostic marker of cardiovascular mortality in patients with chronic kidney disease
by: Baragetti, A., et al.
Published: (2017)
by: Baragetti, A., et al.
Published: (2017)
Long pentraxin 3: Experimental and clinical relevance in cardiovascular diseases
by: Bonacina, F., et al.
Published: (2013)
by: Bonacina, F., et al.
Published: (2013)
The structure and dynamics of plasma high-density lipoproteins and their interactions with the beta-amyloid peptide
by: Malajczuk, Chris
Published: (2022)
by: Malajczuk, Chris
Published: (2022)
Translating the biology of adipokines in atherosclerosis and cardiovascular diseases: Gaps and open questions
by: Ruscica, M., et al.
Published: (2017)
by: Ruscica, M., et al.
Published: (2017)
Statins and periodontal inflammation: A pleiotropic effect of statins or a pleiotropic effect of LDL-cholesterol lowering?
by: Norata, Giuseppe, et al.
Published: (2014)
by: Norata, Giuseppe, et al.
Published: (2014)
Niemann-pick C1-like 1 (NPC1L1) inhibition and cardiovascular diseases
by: Pirillo, A., et al.
Published: (2016)
by: Pirillo, A., et al.
Published: (2016)
Association of backfat thickness with postheparin lipoprotein lipase activity and very low density lipoprotein-subfractions in growing pigs
by: Loh, Teck Chwen, et al.
Published: (2001)
by: Loh, Teck Chwen, et al.
Published: (2001)
Cardiometabolic and immune factors associated with increased common carotid artery intima-media thickness and cardiovascular disease in patients with systemic lupus erythematosus
by: Ammirati, E., et al.
Published: (2014)
by: Ammirati, E., et al.
Published: (2014)
Targeting Cholesterol in Non-ischemic Heart Failure: A Role for LDLR Gene Therapy?
by: Catapano, A., et al.
Published: (2017)
by: Catapano, A., et al.
Published: (2017)
In vitro antioxidant and anti-inflammatory effects of Erythroxylum cuneatum leaf extract on oxidized low-density lipoprotein-stimulated human aortic endothelial cells
by: Adam, Siti Khadijah, et al.
Published: (2023)
by: Adam, Siti Khadijah, et al.
Published: (2023)
Serum high-density lipoprotein is associated with better cognitive function in a cross-sectional study of aging women
by: Bates, K., et al.
Published: (2017)
by: Bates, K., et al.
Published: (2017)
Study of oxidized low density lipoprotein and augmentation index among population
by: Nazir, Mohd Hakam, et al.
Published: (2013)
by: Nazir, Mohd Hakam, et al.
Published: (2013)
Antigen-dependent and antigen-independent pathways modulate CD4 +CD28 null T-cells during atherosclerosis
by: Ammirati, E., et al.
Published: (2012)
by: Ammirati, E., et al.
Published: (2012)
Similar Items
-
Does cigarette smoking exacerbate the effect of total cholesterol and high-density lipoprotein cholesterol on the risk of cardiovascular diseases?
by: Nakamura, K., et al.
Published: (2009) -
Vascular inflammation and low-density lipoproteins: Is cholesterol the link? A lesson from the clinical trials
by: Catapano, A., et al.
Published: (2017) -
Treating high density lipoprotein cholesterol (HDL-C): Quantity versus quality
by: Pirillo, A., et al.
Published: (2013) -
High density lipoprotein cholesterol levels are an independent predictor of the progression of chronic kidney disease
by: Baragetti, A., et al.
Published: (2013) -
Emerging role of high density lipoproteins as a player in the immune system
by: Norata, Giuseppe, et al.
Published: (2012)